Skip to main content

UBS Group AG

Position in KTTA — Pasithea Therapeutics Corp.

CIK 1610520 ZURICH, V8

Position in KTTA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$96,876
+$77,474 QoQ
Shares Held
188,111
+619.4% QoQ
Ownership
0.563%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 25 holders
Holding Since
Sep 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KTTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. KTTA ranks #363 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KTTA

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $96,876 188,111
2026-03-31 $19,402 26,149
2025-12-31 $17,108 13,263
2025-09-30 $13,454 18,381
2025-06-30 $30,384 42,142
2025-03-31 $5,638 4,337
2024-12-31 $40,534 12,868
2024-09-30 $35,593 6,567
2024-06-30 KTTAW 34
2024-06-30 $192 38
2024-03-31 KTTAW 34
2024-03-31 $4,408 608
2023-09-30 KTTAW 100
2023-09-30 $39 83
2023-06-30 $3,392 6,924
2022-12-31 $8,173 12,732
2022-09-30 KTTAW 1,849
2022-09-30 $6,869 5,452
2022-06-30 KTTAW 1,599
2022-06-30 $12,933 12,805
2022-03-31 KTTAW 800
2021-09-30 KTTAW 45
2021-09-30 $10,001 3,290